Filter
137
Filtered Results: 137
Text search:
UNITAID,
WHO,
Global
Laboratory
Initiative,
et.
al
Featured
Recommendations
15
New Publications
29
Language
Document type
No document type
69
Studies & Reports
27
Guidelines
24
Strategic & Response Plan
8
Manuals
5
Training Material
1
Brochures
1
Infographics
1
Fact sheets
1
Countries / Regions
Global
5
India
4
Ethiopia
3
Africa
3
Eastern Europe
3
Burkina Faso
2
Cameroon
2
Uganda
2
Kenya
2
Mozambique
2
Myanmar / Burma
2
Western and Central Europe
2
Liberia
1
Nigeria
1
Bangladesh
1
Malawi
1
Brazil
1
Middle East and North Africa
1
Asia
1
Timor Leste/ East Timor
1
Moldova
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
28
Countries
27
Pharmacy & Technologies
6
Women & Child Health
5
Public Health
4
Key Resources
2
Toolboxes
HIV
49
TB
28
AMR
4
COVID-19
4
Health Financing Toolbox
4
Rapid Response
2
Mental Health
2
Pharmacy
2
Ebola
1
Refugee
1
Caregiver
1
NCDs
1
Almost half (46%) of the world’s 1.7 million children living with HIV were not on treatment in 2020 and 150 000 children were newly infected with HIV, four times more than the 2020 target of 40 000
Technical Note on Antimicrobial Resistance
This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-specific and AMR-sensitive actions in reducing infecti...
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
Rebuilding Liberia’s health system is crucial for improving the country’s overall health outcomes. This annual report highlights key achievements, challenges,and lessons learned in implementing programmes of technical cooperation with the Government of Liberia from January to December 2022. T...
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
Supplement
HIV testing services
December 2016
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region wa...
Tuberculosis cases, TB deaths
TB in India 2017
recommended
Revised National TB Control Programme. Annual Status Report
WHO Information Leaflet COVID-19: Considerations on tuberculosis (TB) care
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, resources, regulatory structures and processes and out...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
High salt consumption is an important determinant of high blood pressure and reducing it would improve health outcomes by lowering cardiovascular disease and therefore death rates. Reducing salt intake has been identified as one of the most effective public health measures and is one of the leading ...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with ... requirements for evidence-based policies.
